慢性阻塞性肺疾病与维生素D的研究进展
Research Progress of Chronic Obstructive Pulmonary Disease and Vitamin D
DOI: 10.12677/ACM.2022.125702, PDF,   
作者: 伏 娜:青海大学研究生院,青海 西宁;崔金霞*:青海大学附属医院呼吸内科,青海 西宁
关键词: 可视化分析慢性阻塞性肺疾病维生素D肺功能雾化Visual Analysis Chronic Obstructive Pulmonary Disease Vitamin D Pulmonary Function Atomization
摘要: 利用VOSviewer对WOS数据库中慢性阻塞性肺疾病和维生素D发表的期刊及关键词进行了数据可视化,了解其研究现状。对关键词进行搜索发现近20余年的研究热点明显增加,维生素D对肺部疾病,尤其是COPD之间的关系日渐清晰。对于COPD的病人补充维生素D有重要意义,但是深入多方面的了解维生素D与慢阻肺的关系、维生素D对慢阻肺的干预作用及干预方式的选择尚需更多,更细致的临床研究。
Abstract: Vosviewer was used to visualize the data of journals and keywords published by chronic obstructive pulmonary disease and vitamin D in WOS database to understand its research status. Searching for keywords, it is found that the research hotspots in recent 20 years have increased significantly, and the relationship between vitamin D and lung diseases, especially COPD, is becoming clearer and clearer. It is of great significance to supplement vitamin D for COPD patients, but more and more detailed clinical research is needed to deeply understand the relationship between vitamin D and COPD, the intervention effect of vitamin D on COPD and the choice of intervention methods.
文章引用:伏娜, 崔金霞. 慢性阻塞性肺疾病与维生素D的研究进展[J]. 临床医学进展, 2022, 12(5): 4844-4852. https://doi.org/10.12677/ACM.2022.125702

参考文献

[1] Fu, L., Fei, J., Tan, Z.X., et al. (2021) Low Vitamin D Status Is Associated with Inflammation in Patients with Chronic Obstructive Pulmonary Disease. The Journal of Immunology, 206, 515-523. [Google Scholar] [CrossRef] [PubMed]
[2] Singh, D., Agusti, A., Anzueto, A., Barnes, P.J., Bourbeau, J., Celli, B.R., Criner, G.J., Frith, P., Halpin, D.M.G., Han, M., López Varela, M.V., Martinez, F., de Oca, M.M., Papi, A., Pavord, I.D., Roche, N., Sin, D.D., Stockley, R., Vestbo, J., Wedzicha, J.A. and Vogelmeier, C. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. European Respiratory Journal, 53, Article ID: 1900164. [Google Scholar] [CrossRef] [PubMed]
[3] Bjelakovic, G., Gluud, L.L., Nikolova, D., et al. (2014) Vitamin D Supplementation for Prevention of Mortality in Adults. Cochrane Database of Systematic Reviews, No. 1, Ar-ticle No. CD007470. [Google Scholar] [CrossRef
[4] Cannell, J.J., Vieth, R., Umhau, J.C., et al. (2006) Epi-demic Influenza and Vitamin D. Epidemiology & Infection, 134, 1129-1140. [Google Scholar] [CrossRef
[5] Liu, P.T., Stenger, S., Li, H., et al. (2006) Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science, 311, 1770-1773. [Google Scholar] [CrossRef] [PubMed]
[6] Hansdottir, S., Monick, M.M., Hinde, S.L., et al. (2008) Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense. The Journal of Im-munology, 181, 7090‑7099. [Google Scholar] [CrossRef] [PubMed]
[7] Martineau, A.R., Jolliffe, D.A., Greenberg, L., et al. (2019) Vitamin D Supplementation to Prevent Acute Respiratory Infections: Individual Participant Data Meta-Analysis. Health Technology Assessment, 23, 1-44. [Google Scholar] [CrossRef] [PubMed]
[8] Plesa, M., Gaudet, M., Mogas, A., et al. (2021) Vitamin D3 Attenuates Vi-ral-Induced Inflammation and Fibrotic Responses in Bronchial Smooth Muscle Cells. Frontiers in Immunology, 12, Arti-cle ID: 715848. [Google Scholar] [CrossRef] [PubMed]
[9] Afzal, S., Lange, P., Bojesen, S.E., Freiberg, J.J. and Nordest-gaard, B.G. (2014) Plasma 25-Hydroxy Vitamin D, Lung Function and Risk of Chronic Obstructive Pulmonary Disease. Thorax, 69, 24-31. [Google Scholar] [CrossRef] [PubMed]
[10] Hejazi, M.E., Modarresi-Ghazani, F. and Entezari-Maleki, T. (2016) A Review of Vitamin D Effects on Common Respiratory Diseases: Asthma, Chronic Obstructive Pulmonary Disease, and Tuberculosis. Journal of Research in Pharmacy Practice, 5, 7-15. [Google Scholar] [CrossRef
[11] Moberg, M., Ringbaek, T., Roberts, N.B. and Vestbo, J. (2014) Association between Vitamin D Status and COPD Phenotypes. Lung, 192, 493-497. [Google Scholar] [CrossRef] [PubMed]
[12] Martineau, A.R., Jolliffe, D.A., Hooper, R.L., et al. (2017) Vita-min D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Indi-vidual Participant Data. BMJ, 356, i6583. [Google Scholar] [CrossRef] [PubMed]
[13] 宋颖芳, 赖国祥, 戚好文. 1,25-二羟维生素D3抑制被动致敏人气道平滑肌细胞的增殖[J]. 中国病理生理杂志, 2011, 27(9): 1828-1931.
[14] 丁炎, 崔湧, 李悦, 昌建鈞, 葛鑫, 聂宏光. 维生素D及其受体在吸烟患者中表达水平的研究[J]. 山西医药杂志, 2017, 46(6): 615-617.
[15] Pincikova, T., Paquin-Proulx, D., Sandberg, J.K., Flodström-Tullberg, M. and Hjelte, L. (2017) Clinical Impact of Vitamin D Treatment in Cystic Fibrosis: A Pilot Randomized, Controlled Trial. European Journal of Clinical Nutrition, 71, 203-205. [Google Scholar] [CrossRef] [PubMed]
[16] Amado, C.A., Muñoz, P., García-Unzueta, M., et al. (2021) High Para-thyroid Hormone Predicts Exacerbations in COPD Patients with Hypovitaminosis D. Respiratory Medicine, 182, Article ID: 106416. [Google Scholar] [CrossRef] [PubMed]
[17] Jorde, I., Stegemann-Koniszewski, S., Papra, K., et al. (2021) Association of Serum Vitamin D Levels with Disease Severity, Systemic Inflammation, Prior Lung Function Loss and Exacerbations in a Cohort of Patients with Chronic Obstructive Pulmonary Disease (COPD). Journal of Thoracic Dis-ease, 13, 3597-3609. [Google Scholar] [CrossRef] [PubMed]
[18] Uluçoban, H., Dirol, H. and Özdemir, T. (2021) The Effect of Vitamin D Deficiency in Chronic Obstructive Pulmonary Disease. Turkish Thoracic Journal, 22, 242-246. [Google Scholar] [CrossRef
[19] Ahn, K.M., Kim, S.S., Lee, S.Y., Lee, S.H. and Park, H.W. (2021) Vitamin D Deficiency and Lung Function Decline in Healthy Individuals: A Large Longitudinal Observation Study. Respiratory Medicine, 182, Article ID: 106395. [Google Scholar] [CrossRef] [PubMed]
[20] Wannamethee, S.G., Welsh, P., Papacosta, O., Lennon, L. and Whincup, P. (2021) Vitamin D Deficiency, Impaired Lung Function and Total and Respiratory Mortality in a Cohort of Older Men: Cross-Sectional and Prospective Findings from the British Regional Heart Study. BMJ Open, 11, Article ID: e051560. [Google Scholar] [CrossRef] [PubMed]
[21] Zhu, M., Wang, T., Wang, C. and Ji, Y. (2016) The Associa-tion between Vitamin D and COPD Risk, Severity, and Exacerbation: An Updated Systematic Review and Me-ta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2597-2607. [Google Scholar] [CrossRef
[22] Jolliffe, D.A., Greenberg, L., Hooper, R.L., et al. (2019) Vitamin D to Prevent Exacerbations of COPD: Systematic Review and Meta-Analysis of Individual Participant Data from Random-ised Controlled Trials. Thorax, 74, 337-345. [Google Scholar] [CrossRef] [PubMed]
[23] Ferrari, R., Caram, L.M.O., Tanni, S.E., et al. (2018) The Re-lationship between Vitamin D Status and Exacerbation in COPD Patients—A Literature Review. Respiratory Medicine, 139, 34-38. [Google Scholar] [CrossRef] [PubMed]
[24] Ghosh, A.J., Moll, M., Hayden, L.P., et al. (2020) Vitamin D Deficiency Is Associated with Respiratory Symptoms and Airway Wall Thickening in Smokers with and without COPD: A Prospective Cohort Study. BMC Pulmonary Medicine, 20, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[25] Lokesh, K.S., Chaya, S.K., Jayaraj, B.S., et al. (2021) Vitamin D Deficiency Is Associated with Chronic Obstructive Pulmonary Disease and Exacerbation of COPD. The Clinical Respir-atory Journal, 15, 389-399. [Google Scholar] [CrossRef] [PubMed]
[26] Soeroto, A.Y., Setiawan, D., Asriputri, N.N., Darmawan, G., Laurus, G. and Santoso, P. (2021) Association between Vitamin D Levels and FEV1, Number of Exacerbations, and CAT Score in Stable COPD Patients in Indonesia. International Journal of General Medicine, 14, 7293-7297. [Google Scholar] [CrossRef
[27] Lehouck, A., Mathieu, C., Carremans, C., et al. (2012) High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial. Annals of Internal Medicine, 156, 105-114. [Google Scholar] [CrossRef] [PubMed]
[28] Hornikx, M., Van Remoortel, H., Lehouck, A., et al. (2012) Vitamin D Supplementation during Rehabilitation in COPD: A Secondary Analysis of a Randomized Trial. Respiratory Research, 13, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[29] Zendedel, A., Gholami, M., Anbari, K., Ghanadi, K., Bachari, E.C. and Azargon, A. (2015) Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study. Global Journal of Health Science, 7, 243-248. [Google Scholar] [CrossRef] [PubMed]
[30] Sluyter, J.D., Camargo, C.A., Waayer, D., Lawes, C.M.M., Toop, L., Khaw, K.T. and Scragg, R. (2017) Effect of Monthly, High-Dose, Long-Term Vitamin D on Lung Function: A Ran-domized Controlled Trial. Nutrients, 9, Article No. 1353. [Google Scholar] [CrossRef] [PubMed]
[31] Pourrashid, M.H., Dastan, F., Salamzadeh, J., Eslaminejad, A. and Edalatifard, M. (2018) Role of Vitamin D Replacement on Health-Related Quality of Life in Hospitalized Patients with “Acute Exacerbation of Chronic Obstructive Pulmonary Disease”. The Iranian Journal of Pharmaceutical Research, 17, 801-810.
[32] Alavi Foumani, A., Mehrdad, M., Jafarinezhad, A., Nokani, K. and Jafari, A. (2019) Impact of vitamin D on Spirometry Findings and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Double- Blinded, Placebo-Controlled Clinical Trial. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1495- 1501. [Google Scholar] [CrossRef
[33] Li, X., He, J., Yu, M. and Sun, J. (2020) The Efficacy of Vitamin D Therapy for Patients with COPD: A Meta-Analysis of Randomized Controlled Trials. Annals of Palliative Medicine, 9, 286-297. [Google Scholar] [CrossRef] [PubMed]
[34] Yang, H., Sun, D., Wu, F., et al. (2022) Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis. Computational and Mathematical Methods in Medicine, 2022, Article ID: 2910782. [Google Scholar] [CrossRef] [PubMed]
[35] Moosavi, S.A.J. and Shoushtari, M.H. (2015) The Effects of Vitamin D Supplementation on Pulmonary Function of Chronic Obstructive Pulmonary Disease Patients, Before and af-ter Clinical Trial. Diseases, 3, 253-259. [Google Scholar] [CrossRef] [PubMed]
[36] Dastan, F., Salamzadeh, J., Pourrashid, M.H., Edalatifard, M. and Eslaminejad, A. (2019) Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD, 16, 278-283. [Google Scholar] [CrossRef] [PubMed]
[37] Origuchi, M., Hirokawa, M., Abe, K., Kumagai, H. and Yamashita, C. (2016) Pulmonary Administration of 1,25- Dihydroxyvitamin D3 to the Lungs Induces Alveolar Regener-ation in a Mouse Model of Chronic Obstructive Pulmonary Disease. Journal of Controlled Release, 233, 191-197. [Google Scholar] [CrossRef] [PubMed]
[38] Serré, J., Mathyssen, C., Ajime, T.T., et al. (2022) Local Nebu-lization of 1α,25(OH)2D3 Attenuates LPS-Induced Acute Lung Inflammation. Respiratory Research, 23, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[39] Saleem, A., Sharif, S., Jarvis, S., Madouros, N., Koumadoraki, E. and Khan, S. (2021) A Comprehensive Review on Vitamin D as a Novel Therapeutic Agent in Chronic Obstructive Pulmonary Disease. Cureus, 13, Article ID: e13095. [Google Scholar] [CrossRef] [PubMed]